tiprankstipranks
Trending News
More News >
Ligand price target raised to $145 from $142 at Oppenheimer
PremiumThe FlyLigand price target raised to $145 from $142 at Oppenheimer
2M ago
Ligand Pharma’s Strong Q1 Performance and Strategic Moves Justify Buy Rating with $135 Price Target
Premium
Ratings
Ligand Pharma’s Strong Q1 Performance and Strategic Moves Justify Buy Rating with $135 Price Target
2M ago
Ligand Pharmaceuticals Reports Strong Q1 2025 Revenue Growth
Premium
Company Announcements
Ligand Pharmaceuticals Reports Strong Q1 2025 Revenue Growth
2M ago
LGND Earnings this Week: How Will it Perform?
PremiumPre-EarningsLGND Earnings this Week: How Will it Perform?
2M ago
Ligand Pharma Announces Merger to Enhance ZELSUVMI Sales
Premium
Company Announcements
Ligand Pharma Announces Merger to Enhance ZELSUVMI Sales
3M ago
Ligand subsidiaries, Chromocell Therapeutics to merge
Premium
The Fly
Ligand subsidiaries, Chromocell Therapeutics to merge
3M ago
Ligand reports Q4 adjusted EPS $1.27, consensus $1.19
PremiumThe FlyLigand reports Q4 adjusted EPS $1.27, consensus $1.19
4M ago
Ligand stiill sees FY25 EPS $6.00-$6.25, consensus $6.14
Premium
The Fly
Ligand stiill sees FY25 EPS $6.00-$6.25, consensus $6.14
4M ago
Ligand Pharma Enters $75M Agreement with Castle Creek
Premium
Company Announcements
Ligand Pharma Enters $75M Agreement with Castle Creek
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100